• About
    • Leadership
    • Medical Advisory Board
    • Conditions We Treat
    • Careers
  • Science
    • Product
    • Procedure
    • History
  • Clinical Trials
  • Press
    • Allotex in the News
    • Press Releases
    • Media Assets
  • Contact
  • Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to footer

Allotex

Allograft Inlays & Onlays

  • About
    • Leadership
    • Medical Advisory Board
    • Conditions We Treat
    • Careers
  • Science
    • Product
    • Procedure
    • History
  • Clinical Trials
  • Press
    • Allotex in the News
    • Press Releases
    • Media Assets
  • Contact
    • Twitter

The Natural Solution for Vision Correction

Because we use allograft tissue, our implants can be right beneath the surface of the eye—making our treatment the least invasive of all refractive procedures.

Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia. The therapy is accomplished through tissue addition technology that uses precisely-shaped human corneal allografts to create what is essentially a permanent, living contact lens or lens insert.

Allotex is a start-up company led by Drs. David Muller and Michael Mrochen.

Learn More

Footer

Contact

Allotex, Inc.
27-43 Wormwood Street
Suite 160
Boston MA 02210
617-391-9544

Copyright © 2014 - 2019 Allotex, Inc. · All Rights Reserved · Privacy Policy · Site design and development by Sky Dog Technologies